Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sana Biotechnology Inc (SANA) vs Symbotic Inc (SYM) Price & Performance

Sana Biotechnology IncTrade
Symbotic IncTrade

Price performance (Past 24H)

Key statistics

Sana Biotechnology Inc vs Symbotic Inc — how do they compare? Sana Biotechnology Inc trades at $3.82 (market cap $1.13B), while Symbotic Inc trades at $41.21 (market cap $5.41B). The key difference: Symbotic Inc is far larger — about 4.8× Sana Biotechnology Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals.

SANASYM
Market Cap
$1.13B$5.41B
Sector
HealthTechnology
52-Week High
$5.92$87.30
52-Week Low
$2.68$38.57
Enterprise Value
$1.05B$3.67B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sana Biotechnology Inc

SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.

The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.

Symbotic Inc

SYM trades at $41.15, up 2.59% with recent earnings misses creating volatility. The stock shows bearish technical signals despite analyst optimism, with revenue growth of 21.7% in Q3 2026 but declining profitability margins. Recent institutional selling and insider transactions add complexity to the investment case.

Outlook remains mixed with strong revenue growth potential offset by margin pressures and recent earnings disappointments. The consensus price target of $60 suggests 46% upside, but investors face execution risks and competitive threats in the automation sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA

About Symbotic Inc

Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.

Read more on SYM